Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.30 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.30 |
| ▸ | BRD4 | O60885 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25106815 | 0.88 | POLB (0.40) | POLBNR1H2NR1H3 | |
| SCHEMBL25106709 | 0.86 | POLB (0.34) | POLBNR1H2NR1H3 | |
| SCHEMBL25106820 | 0.85 | LMNA (0.35) | LMNAHTTSMN1; SMN2POLB | |
| SCHEMBL25106814 | 0.85 | NR1H2 (0.33) | NR1H2NR1H3 | |
| SCHEMBL25106842 | 0.83 | NR1H2 (0.32) | NR1H2NR1H3 | |
| SCHEMBL25106952 | 0.80 | NR1H2 (0.33) | NR1H2NR1H3 | |
| SCHEMBL25106845 | 0.79 | NR1H2 (0.32) | NR1H2NR1H3 | |
| SCHEMBL25106694 | 0.78 | POLB (0.41) | POLBNR1H2NR1H3 | |
| SCHEMBL14677115 | 0.77 | LMNA (0.38) | LMNAHTTSMN1; SMN2POLBBRD4 | |
| SCHEMBL29431631 | 0.77 | LMNA (0.38) | LMNAHTTSMN1; SMN2POLBBRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230060425-A1 | FUSED BICYCLIC HETEROCYCLE DERIVATIVES AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2023-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230060425-A1 | FUSED BICYCLIC HETEROCYCLE DERIVATIVES AS PESTICIDES | DDT, CBR1, CBR3 | LMNA 1965/4885HTT 1154/4885SMN1; SMN2 3634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.